Targeted cell entry of lentiviral vectors

Molecular Therapy

Volumn 16, Issue 8, 2008, Pages 1427-1436

  Funke, Sabrina ^a   Maisner, Andrea ^b   Mühlebach, Michael D ^a   Koehl, Ulrike ^c   Grez, Manuel ^d   Cattaneo, Roberto ^e   Cichutek, Klaus ^a   Buchholz, Christian J ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^d INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^e MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOPROTEIN; HEMAGGLUTININ; HYBRID PROTEIN; LENTIVIRUS VECTOR; VIRUS PROTEIN;

ARTICLE; B LYMPHOCYTE; CELL MEMBRANE; CELL POPULATION; CONTROLLED STUDY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MEASLES VIRUS; MEMBRANE FUSION; PROTEIN TARGETING; PSEUDOTYPING; SUICIDE GENE THERAPY; TARGET CELL; VESICULAR STOMATITIS VIRUS;

ANIMALS; ANTIGENS, CD20; B-LYMPHOCYTES; BLOTTING, WESTERN; CELL LINE; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; FLOW CYTOMETRY; GENETIC VECTORS; HEMAGGLUTININS; HIV-1; HUMANS; LENTIVIRUS; MEASLES VIRUS; POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSDUCTION, GENETIC; VIRAL FUSION PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS 1; MEASLES VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 48349147731     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2008.128     Document Type: Article

References (50)

1. Cockrell, AS and Kafri, T (2007). Gene delivery by lentivirus vectors. Mol Biotechnol 36: 184-204.
2. Levine, BL, Humeau, LM, Boyer, J, MacGregor, RR, Rebello, T, Lu, X et al. (2006). Gene transfer in humans using a conditionally replicating lentiviral vector. Proc Natl Acad Sci USA 103: 17372-17377.
3. Brown, BD, Venneri, MA, Zingale, A, Sergi, SL and Naldini, L (2006). Endogenous microRNA regulation suppresses transgene expression in hematopoietic: Lineages and enables stable gene transfer. Nat Med 12: 585-591.
4. Schnierle, BS, Stitz, J, Bosch, V, Nocken, F, Merget-Millitzer, H, Engelstadter, M et al. (1997). Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc Natl Acad Sci USA 94: 8640-8645.
5. Miletic, H, Fischer, YH, Neumann, H, Hans, V, Stenzel, W, Giroglou, T et al. (2004). Selective transduction of malignant glioma by lentiviral vectors pseudotyped with lymphocytic choriomeningitis virus glycoproteins. Hum Gene Ther 15: 1091-1100.
6. Sakalian, M and Hunter, E (1998). Molecular events in the assembly of retrovirus particles. Adv Exp Med Biol 440: 329-339.
7. Sandrin, V, Muriaux, D, Darlix, JL and Cosset, FL (2004). Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses. J Virol 78: 7153-7164.
8. Christodoulopoulos, I and Cannon, PM (2001). Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors. J Virol 75 4129-4138.
9. Merten, CA, Stitz, J, Braun, G, Poeschla, EM, Cichutek, K and Buchholz, CJ (2005). Directed evolution of retrovirus envelope protein cytoplasmic tails guided by functional incorporation into lentivirus particles. J Virol 79: 834-840.
10. Buchholz, CJ, Duerner, LJ, Funke, S and Schneider, IC (2008). Retroviral display and high throughput screening. Comb Chem High Throughput Screen 11: 99-110.
11. Sandrin, V, Russell, SJ and Cosset, FL (2003). Targeting retroviral and lentiviral vectors. Curr Top Microbiol Immunol 281: 137-178.
12. Hartl, I, Schneider, RM, Sun, Y, Medvedovska, J, Chadwick, MP, Russell, SJ et al. (2005). Library-based selection of retroviruses selectively spreading through matrix metalloprotease-positive cells. Gene Ther 12: 918-926.
13. Szecsi, J, Drury, R, Josserand, V, Grange, MP, Boson, B, Hartl, I et al. (2006). Targeted retroviral vectors displaying a cleavage site-engineered hemagglutinin (HA) through HA-protease interactions. Mol Ther 14: 735-744.
14. Morizono, K, Xie, Y, Ringpis, GE, Johnson, M, Nassanian, H, Lee, B et al. (2005). Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection. Nat Med 11 346-352.
15. Yang, L, Bailey, L, Baltimore, D and Wang, P (2006). Targeting lentiviral vectors to specific cell types in vivo. Proc Natl Acad Sci USA 103: 11479-11484.
16. Yanagi, Y, Takeda, M and Ohno, S (2006). Measles virus: Cellular receptors, tropism and pathogenesis. J Gen Virol 87: 2767-2779.
17. Moll, M, Klenk, HD and Maisner, A (2002). Importance of the cytoplasmic tails of the measles virus glycoproteins for fusogenic activity and the generation of recombinant measles viruses. J Virol 76: 7174-7186.
18. Vongpunsawad, S, Oezgun, N, Braun, W and Cattaneo, R (2004). Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model. J Virol 78: 302-313.
19. Nakamura, T, Peng, KW, Harvey, M, Greiner, S, Lorimer, IA, James, CD et al. (2005). Rescue and propagation of fully retargeted oncolytic measles viruses. Nat Biotechnol 23: 209-214.
20. Hammond, AL, Plemper, RK, Zhang, J, Schneider, U, Russell, SJ and Cattaneo, R (2001). Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen. J Virol 75: 2087-2096.
21. Paraskevakou, G, Allen, C, Nakamura, T, Zollman, P, James, CD, Peng, KW et al. (2007). Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas. Mol Ther 15: 677-686.
22. Ungerechts, G, Springfeld, C, Frenzke, ME, Lampe, J, Johnston, PB, Parker, WB et al. (2007). Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can synergize with fludarabine. Cancer Res 67: 10939-10947.
23. Liu, ML, Winther, BL and Kay, MA (1996). Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors: Comparison of VSV-G and amphotropic vectors for hepatic gene transfer. J Virol 70: 2497-2502.
24. Cattaneo, R, Rebmann, G, Schmid, A, Baczko, K, ter Meulen, V and Billeter, MA (1987). Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J 6: 681-688.
25. Blakely, BT, Rossi, FM, Tillotson, B, Palmer, M, Estelles, A and Blau, HM (2000). Epidermal growth factor receptor dimerization monitored in live cells. Nat Biotechnol 18: 218-222.
26. Haigler, H, Ash, JF, Singer, SJ and Cohen, S (1978). Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431. Proc Natl Acad Sci USA 75: 3317-3321.
27. Junker, K, Koehl, U, Zimmerman, S, Stein, S, Schwabe, D, Klingebiel, T et al. (2003). Kinetics of cell death in T lymphocytes genetically modified with two novel suicide fusion genes. Gene Ther 10: 1189-1197.
28. Gallardo, HF, Tan, C, Ory, D and Sadelain, M (1997). Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoprotein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes. Blood 90: 952-957.
29. Chun, TW, Stuyver, L, Mizell, SB, Ehler, LA, Mican, JA, Baseler, M et al. (1997). Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci USA 94 13193-13197.
30. Cosset, FL, Morling, FJ, Takeuchi, Y, Weiss, RA, Collins, MK and Russell, SJ (1995). Retroviral retargeting by envelopes expressing an N-terminal binding domain. J Virol 69: 6314-6322.
31. Glennie, MJ, French, RR, Cragg, MS and Taylor, RP (2007). Mechanisms of killing by anti-CD20 monoclonal antibodies. Mol Immunol 44: 3823-3837.
32. Plumet, S, Duprex, WP and Gerlier, D (2005). Dynamics of viral RNA synthesis during measles virus infection. J Virol 79: 6900-6908.
33. Bovia, F, Salmon, P, Matthes, T, Kvell, K, Nguyen, TH, Werner-Favre, C et al. (2003). Efficient transduction of primary human B lymphocytes and nondividing myeloma B cells with HIV-1-derived lentiviral vectors. Blood 101: 1727-1733.
34. Zubler, RH (2001). Naive and memory B cells in T-cell-dependent and T-independent responses. Springer Semin Immunopathol 23: 405-419.
35. Janssens, W, Chuah, MK, Naldini, L, Follenzi, A, Collen, D, Saint-Remy, JM et al. (2003). Efficiency of onco-retroviral and lentiviral gene transfer into primary mouse and human B-lymphocytes is pseudotype dependent. Hum Gene Ther 14: 263-276.
36. Verhoeyen, E, Dardalhon, V, Ducrey-Rundquist, O, Trono, D, Taylor, N and Cosset, FL (2003). IL-7 surface-engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytes. Blood 101: 2167-2174.
37. Verhoeyen, E, Wiznerowicz, M, Olivier, D, Izac, B, Trono, D, Dubart-Kupperschmitt, A et al. (2005). Novel lentiviral vectors displaying "early-acting cytokines" selectively promote survival and transduction of NOD/SCID repopulating human hematopoietic stem cells. Blood 106: 3386-3395.
38. Tedder, TF and Engel, P (1994). CD20: A regulator of cell-cycle progression of B lymphocytes. Immunol Today 15: 450-454.
39. Smeland, E, Godal, T, Ruud, E, Beiske, K, Funderud, S, Clark, EA et al. (1985). The specific induction of myc protooncogene expression in normal human B cells is not a sufficient event for acquisition of competence to proliferate. Proc Natl Acad Sci USA 82: 6255-6259.
40. Clark, EA, Shu, G and Ledbetter, JA (1985). Role of the Bp35 cell surface polypeptide in human B-cell activation. Proc Natl Acad Sci USA 82: 1766-1770.
41. Cathomen, T, Buchholz, CJ, Spielhofer, P and Cattaneo, R (1995). Preferential initiation at the second AUG of the measles virus F mRNA: A role for the long untranslated region. Virology 214: 628-632.
42. Cathomen, T, Naim, HY and Cattaneo, R (1998). Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J Virol 72: 1224-1234.
43. Buchholz, CJ, Peng, KW, Morling, FJ, Zhang, J, Cosset, FL and Russell, SJ (1998). In vivo selection of protease cleavage sites from retrovirus display libraries. Nat Biotechnol 16: 951-954.
44. Demaison, C, Parsley, K, Brouns, G, Scherr, M, Battmer, K, Kinnon, C et al. (2002). High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum Gene Ther 13: 803-813.
45. Folks, T, Benn, S, Rabson, A, Theodore, T, Hoggan, MD, Martin, M et al. (1985). Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus. Proc Natl Acad Sci USA 82: 4539-4543.
46. Bucheit, AD, Kumar, S, Grote, DM, Lin, Y, von, MV, Cattaneo, RB et al. (2003). An oncolytic measles virus engineered to enter cells through the CD20 antigen. Mol Ther 7: 62-72.
47. Nakamura, T, Peng, KW, Vongpunsawad, S, Harvey, M, Mizuguchi, H, Hayakawa, T et al. (2004). Antibody-targeted cell fusion. Nat Biotechnol 22: 331-336.
48. Zufferey, R, Nagy, D, Mandel, RJ, Naldini, L and Trono, D (1997). Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15: 871-875.
49. Miyoshi, H, Takahashi, M, Gage, FH and Verma, IM (1997). Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci USA 94: 10319-10323.
50. Soneoka, Y, Cannon, PM, Ramsdale, EE, Griffiths, JC, Romano, G, Kingsman, SM et al. (1995). A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res 23: 628-633.